BICLUSTER_ID : DNREG-38
PATHOGENS /3/ : lactobacillus acidophilus,helicobacter pylori,burkholderia pseudomallei
TARGETS /24/ : MGST3, NDUFB8, CSNK1G2, TUBB3, NDUFB5, NDUFS8, BLVRA, SDHC, CYB5A, NDUFA8, UQCRC1, NDUFB7, APEX1, NDUFS6, TUBB, PARP1, BCAT2, IDH1, NDUFA4, TUBB2C, PPIB, TK1, DHCR7, NDUFC1
Gene SetLeading Edge Genes
SPIELMAN LYMPHOBLAST EUROPEAN VS ASIAN UPKIF20A, PCK2, ATP5I, NDUFB8, POLR2I, CSNK1G2, TUBB3, EI24, HMGB3, NDUFS8, BLOC1S1, CENPF, DBI, AES, UQCRC1, MBD3, TUBB, UBE2C, BCAT2, ATP5J2, KIF22, PPIB, ARHGAP1, HMBS, EBP, RTN3, H2AFX, NUDT3, HMGB1, FKBP2, CDC20, PARP1, TMC6, ETV5, H2AFV, PSMB3, DHCR7, ERH
MOOTHA VOXPHOSATP5I, ATP5C1, UQCR, NDUFB8, ATP5H, NDUFB5, NDUFS8, CYB5A, SDHC, NDUFA8, UQCRC1, NDUFS6, MBD3, ATP5J2, NDUFA4, ATP5E, UQCRC2, NDUFC1
ACEVEDO LIVER TUMOR VS NORMAL ADJACENT TISSUE UPSET, CETN2, ILF2, MGST3, ANKMY2, SDF2L1, BLVRA, ICT1, NDUFA8, THAP11, APEX1, WRB, PDIA6, BCAT2, DDX46, CDR2, RNASEH2A, TK1, ASPM, NUDT2, ARL2BP, NUCB2, GNPAT, MRPL40, CKAP4, H2AFX, PPP1CA, CCNA2, GMNN, MSH6, CDC20, PARP1, IDH1, PURA, ZMPSTE24, TUBB2C, SUV39H1, IMPAD1
CORUM RESPIRATORY CHAIN COMPLEX I HOLOENZYME MITOCHONDRIALNDUFA4, NDUFB7, NDUFS8, NDUFB11, NDUFB8, NDUFC1, NDUFA8
LOPEZ MESOTELIOMA SURVIVAL TIME UP
WILCOX PRESPONSE TO ROGESTERONE UP
KEGG CITRATE CYCLE TCA CYCLE
NAKAYAMA SOFT TISSUE TUMORS PCA2 UP
SCHLOSSER SERUM RESPONSE AUGMENTED BY MYC
GRADE COLON CANCER UP
DEBIASI APOPTOSIS BY REOVIRUS INFECTION DN
HASLINGER B CLL WITH 17P13 DELETION
BORCZUK MALIGNANT MESOTHELIOMA UP
MONTERO THYROID CANCER POOR SURVIVAL UP
BHATTACHARYA EMBRYONIC STEM CELL
ALONSO METASTASIS UP
KUMAMOTO RESPONSE TO NUTLIN 3A DN
NCI MITOTIC TELOPHASE CYTOKINESIS
SHEPARD BMYB TARGETS
NCI PHOSPHORYLATION OF THE APC C
STEIN ESRRA TARGETS
THEILGAARD NEUTROPHIL AT SKIN WOUND DN
NCI PLK1 PATHWAY
IVANOVA HEMATOPOIESIS INTERMEDIATE PROGENITOR
MARKEY RB1 CHRONIC LOF UP
SANA RESPONSE TO IFNG DN
CAFFAREL RESPONSE TO THC DN
REACTOME CENTROSOME MATURATION
CORUM F1F0-ATP SYNTHASE EC 3.6.3.14 MITOCHONDRIAL
BUYTAERT PHOTODYNAMIC THERAPY STRESS DN
LOPEZ MBD TARGETS
NCI APC C CDC20 MEDIATED DEGRADATION OF MITOTIC PROTEINS
WONG MITOCHONDRIA GENE MODULE
NCI AURORA A PATHWAY
REACTOME G2 M TRANSITION
REACTOME GLUCOSE REGULATION OF INSULIN SECRETION
REACTOME METABOLISM OF PROTEINS
SASAKI ADULT T CELL LEUKEMIA
KEGG GLUTATHIONE METABOLISM
KEGG TERPENOID BACKBONE BIOSYNTHESIS
HONRADO BREAST CANCER BRCA1 VS BRCA2
CORUM CTCF-NUCLEOPHOSMIN-PARP-HIS-KPNA-LMNA-TOP COMPLEX
PASQUALUCCI LYMPHOMA BY GC STAGE DN
REACTOME CHOLESTEROL BIOSYNTHESIS
REACTOME FORMATION OF ATP BY CHEMIOSMOTIC COUPLING
KEGG BUTANOATE METABOLISM
BIOCARTA MPR PATHWAY
STARK PREFRONTAL CORTEX 22Q11 DELETION DN
PENG LEUCINE DEPRIVATION DN
UDAYAKUMAR MED1 TARGETS UP
PUIFFE INVASION INHIBITED BY ASCITES UP
REACTOME INACTIVATION OF APC VIA DIRECT INHIBITION OF THE APCOMPLEX
SHEPARD CRUSH AND BURN MUTANT DN
XU HGF SIGNALING NOT VIA AKT1 48HR DN
KEGG VALINE LEUCINE AND ISOLEUCINE DEGRADATION
REACTOME APCDC20 MEDIATED DEGRADATION OF CYCLIN B
SESTO RESPONSE TO UV C6
TANG SENESCENCE TP53 TARGETS DN
PENG GLUTAMINE DEPRIVATION DN
NCI REGULATION OF APC C ACTIVATORS BETWEEN G1 S AND EARLY ANAPHASE
REACTOME TRANSFORMATION OF LANOSTEROL TO CHOLESTEROL
FARMER BREAST CANCER APOCRINE VS BASAL
NCI BETA OXIDATION OF DECANOYL COA TO OCTANOYL COA COA
GOLDRATH ANTIGEN RESPONSE
NCI FOXM1PATHWAY
NCI TRANSFORMATION OF LANOSTEROL TO CHOLESTEROL
BENPORATH CYCLING GENES
REACTOME ELECTRON TRANSPORT CHAIN
YAO TEMPORAL RESPONSE TO PROGESTERONE CLUSTER 12
OHASHI AURKB TARGETS
CORUM RC COMPLEX DURING G2/M-PHASE OF CELL CYCLE
YAO TEMPORAL RESPONSE TO PROGESTERONE CLUSTER 13
KEGG PARKINSONS DISEASE
PRAMOONJAGO SOX4 TARGETS DN
KEGG HUNTINGTONS DISEASE
REACTOME INTEGRATION OF ENERGY METABOLISM
LEE LIVER CANCER SURVIVAL DN
KEGG OOCYTE MEIOSIS
NCI BETA OXIDATION OF OCTANOYL COA TO HEXANOYL COA
NCI APC CDC20 MEDIATED DEGRADATION OF NEK2A
KEGG PROPANOATE METABOLISM
REACTOME DIABETES PATHWAYS
MOOTHA MITOCHONDRIA
DAIRKEE TERT TARGETS UP
TARTE PLASMA CELL VS B LYMPHOCYTE UP
STEIN ESRRA TARGETS UP
RICKMAN TUMOR DIFFERENTIATED WELL VS POORLY UP
CHEN HOXA5 TARGETS 9HR DN
POMEROY MEDULLOBLASTOMA PROGNOSIS DN
FINETTI BREAST CANCER BASAL VS LUMINAL
RAMASWAMY METASTASIS UP
NCI RECRUITMENT OF MITOTIC CENTROSOME PROTEINS AND COMPLEXES
REACTOME REGULATION OF INSULIN SECRETION
LY AGING MIDDLE DN
ACEVEDO NORMAL TISSUE ADJACENT TO LIVER TUMOR DN
FINETTI BREAST CANCER KINOME RED
NCI INACTIVATION OF APC C VIA DIRECT INHIBITION OF THE APC C COMPLEX
BIOCARTA AKAP95 PATHWAY
NUYTTEN NIPP1 TARGETS DN
OUELLET CULTURED OVARIAN CANCER INVASIVE VS LMP UP
NCI FORMATION OF ATP BY CHEMIOSMOTIC COUPLING
KEGG PYRUVATE METABOLISM
CORUM OLIGOSACCHARYLTRANSFERASE COMPLEX STT3B VARIANT
CORUM RC COMPLEX DURING S-PHASE OF CELL CYCLE
CAIRO HEPATOBLASTOMA UP
KEGG PROGESTERONE MEDIATED OOCYTE MATURATION
REACTOME PHOSPHORYLATION OF THE APC
LINDGREN BLADDER CANCER CLUSTER 1 DN
Color legend
q-value-1-0.2-0.05-0.01-0.001-0.0001
Color
TABLE OF Q-VALUES
helicobacter pylori kx2 npgecburkholderia pseudomalleilactobacillus acidophilushelicobacter pylori kx2 mgephelicobacter pylori kx1 npgecGeneSet Name
-0.00740 -0.00050 -0.00055 -0.01305 -0.00205SPIELMAN_LYMPHOBLAST_EUROPEAN_VS_ASIAN_UP
-0.00217 -0.00001 -0.00010 -0.02663 -0.00036MOOTHA_VOXPHOS
-0.00489 -0.00532 -0.00129 -0.06916 -0.00733ACEVEDO_LIVER_TUMOR_VS_NORMAL_ADJACENT_TISSUE_UP
-0.00691 -0.00033 -0.00004 -0.06632 -0.00042CORUM_RESPIRATORY_CHAIN_COMPLEX_I_HOLOENZYME_MITOCHONDRIAL
-0.02710 -0.04587 -0.00399 -0.03218 -0.10536LOPEZ_MESOTELIOMA_SURVIVAL_TIME_UP
-0.07181 -0.02750 -0.01815 -0.05284 -0.02611WILCOX_PRESPONSE_TO_ROGESTERONE_UP
-0.00200 -0.00078 -0.00041 -0.10206 -0.00044KEGG_CITRATE_CYCLE_TCA_CYCLE
-0.01845 -0.00013 -0.00004 -0.09230 -0.02188NAKAYAMA_SOFT_TISSUE_TUMORS_PCA2_UP
-0.01338 -0.10712 -0.17298 -0.08425 -0.01278SCHLOSSER_SERUM_RESPONSE_AUGMENTED_BY_MYC
-0.02622 -0.00534 -0.00308 -0.12859 -0.01467GRADE_COLON_CANCER_UP
-0.02742 -0.12467 -0.00511 -0.00144 -0.00577DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_DN
-0.03241 -0.16861 -0.17650 -0.13670 -0.02084HASLINGER_B_CLL_WITH_17P13_DELETION
-0.00017 -0.00016 -0.00187 -0.04124 -0.00038BORCZUK_MALIGNANT_MESOTHELIOMA_UP
-0.00121 -0.00042 -0.00006 -0.07595 -0.00349MONTERO_THYROID_CANCER_POOR_SURVIVAL_UP
-0.01840 -0.00068 -0.04152 -0.12498 -0.02516BHATTACHARYA_EMBRYONIC_STEM_CELL
-0.01661 -0.01842 -0.09912 -0.19829 -0.00963ALONSO_METASTASIS_UP
-0.04464 -0.00073 -0.00892 -0.08113 -0.08108KUMAMOTO_RESPONSE_TO_NUTLIN_3A_DN
-0.14677 -0.06173 -0.05067 -0.16617 -0.10592NCI_MITOTIC_TELOPHASE__CYTOKINESIS
-0.09506 -0.00149 -0.00703 -0.00161 -0.19787SHEPARD_BMYB_TARGETS
-0.00119 -0.01882 -0.15065 -0.06727 -0.00888NCI_PHOSPHORYLATION_OF_THE_APC_C
-0.00737 -0.12577 -0.00110 -0.01868 -0.00531STEIN_ESRRA_TARGETS
-0.03797 -0.00036 -0.12158 -0.02112 -0.02184THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_DN
-0.00213 -0.00005 -0.00001 -0.10251 -0.01899NCI_PLK1_PATHWAY
-0.00463 -0.00001 -0.00436 -0.14035 -0.05506IVANOVA_HEMATOPOIESIS_INTERMEDIATE_PROGENITOR
-0.09283 -0.00582 -0.00856 -0.06736 -0.01075MARKEY_RB1_CHRONIC_LOF_UP
-0.00979 -0.02533 -0.00201 -0.15550 -0.00182SANA_RESPONSE_TO_IFNG_DN
-0.00260 -0.00117 -0.01395 -0.06081 -0.00243CAFFAREL_RESPONSE_TO_THC_DN
-0.01435 -0.03691 -0.09600 -0.04721 -0.00297REACTOME_CENTROSOME_MATURATION
-0.00786 -0.03491 -0.07899 -0.01359 -0.00206CORUM_F1F0-ATP_SYNTHASE_EC_3.6.3.14_MITOCHONDRIAL
-0.00546 -0.00001 -0.00008 -0.07568 -0.00339BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_DN
-0.02818 -0.00177 -0.05131 -0.12405 -0.00897LOPEZ_MBD_TARGETS
-0.00684 -0.00947 -0.11114 -0.07750 -0.02086NCI_APC_C_CDC20_MEDIATED_DEGRADATION_OF_MITOTIC_PROTEINS
-0.00182 -0.00046 -0.00183 -0.10879 -0.00100WONG_MITOCHONDRIA_GENE_MODULE
-0.00370 -0.02454 -0.02572 -0.17913 -0.01341NCI_AURORA_A_PATHWAY
-0.00735 -0.03193 -0.00886 -0.04505 -0.00240REACTOME_G2_M_TRANSITION
-0.02041 -0.00096 -0.00063 -0.10197 -0.00233REACTOME_GLUCOSE_REGULATION_OF_INSULIN_SECRETION
-0.10049 -0.16675 -0.17867 -0.00285 -0.09674REACTOME_METABOLISM_OF_PROTEINS
-0.00079 -0.00006 -0.12943 -0.04079 -0.00349SASAKI_ADULT_T_CELL_LEUKEMIA
-0.00513 -0.04259 -0.03917 -0.03476 -0.00223KEGG_GLUTATHIONE_METABOLISM
-0.02041 -0.16673 -0.19993 -0.02284 -0.00494KEGG_TERPENOID_BACKBONE_BIOSYNTHESIS
-0.06442 -0.00426 -0.03586 -0.10610 -0.05999HONRADO_BREAST_CANCER_BRCA1_VS_BRCA2
-0.06791 -0.04731 -0.18289 -0.06310 -0.02545CORUM_CTCF-NUCLEOPHOSMIN-PARP-HIS-KPNA-LMNA-TOP_COMPLEX
-0.10714 -0.00334 -0.15621 -0.04512 -0.07162PASQUALUCCI_LYMPHOMA_BY_GC_STAGE_DN
-0.01585 -0.12827 -0.00604 -0.00656 -0.00080REACTOME_CHOLESTEROL_BIOSYNTHESIS
-0.01571 -0.05144 -0.08618 -0.00605 -0.00297REACTOME_FORMATION_OF_ATP_BY_CHEMIOSMOTIC_COUPLING
-0.01875 -0.15599 -0.16729 -0.11312 -0.01078KEGG_BUTANOATE_METABOLISM
-0.00061 -0.09646 -0.12283 -0.00166 -0.00292BIOCARTA_MPR_PATHWAY
-0.00430 -0.00725 -0.00020 -0.05369 -0.00086STARK_PREFRONTAL_CORTEX_22Q11_DELETION_DN
-0.00901 -0.03319 -0.00030 -0.03129 -0.02746PENG_LEUCINE_DEPRIVATION_DN
-0.02703 -0.00040 -0.00066 -0.08936 -0.01394UDAYAKUMAR_MED1_TARGETS_UP
-0.03117 -0.00558 -0.15776 -0.17608 -0.04662PUIFFE_INVASION_INHIBITED_BY_ASCITES_UP
-0.00281 -0.01448 -0.04943 -0.09045 -0.00671REACTOME_INACTIVATION_OF_APC_VIA_DIRECT_INHIBITION_OF_THE_APCOMPLEX
-0.07577 -0.02242 -0.00916 -0.18475 -0.12253SHEPARD_CRUSH_AND_BURN_MUTANT_DN
-0.02144 -0.00299 -0.00080 -0.07933 -0.01028XU_HGF_SIGNALING_NOT_VIA_AKT1_48HR_DN
-0.00079 -0.12647 -0.00666 -0.00209 -0.00054KEGG_VALINE_LEUCINE_AND_ISOLEUCINE_DEGRADATION
-0.00203 -0.02193 -0.14447 -0.06321 -0.00873REACTOME_APCDC20_MEDIATED_DEGRADATION_OF_CYCLIN_B
-0.00058 -0.04011 -0.01350 -0.11512 -0.00278SESTO_RESPONSE_TO_UV_C6
-0.01416 -0.00127 -0.00887 -0.04893 -0.02427TANG_SENESCENCE_TP53_TARGETS_DN
-0.01410 -0.00050 -0.00029 -0.16100 -0.02533PENG_GLUTAMINE_DEPRIVATION_DN
-0.00014 -0.01297 -0.02258 -0.06693 -0.00012NCI_REGULATION_OF_APC_C_ACTIVATORS_BETWEEN_G1_S_AND_EARLY_ANAPHASE
-0.05807 -0.13439 -0.00068 -0.08274 -0.01616REACTOME_TRANSFORMATION_OF_LANOSTEROL_TO_CHOLESTEROL
-0.03829 -0.18074 -0.14415 -0.05512 -0.01962FARMER_BREAST_CANCER_APOCRINE_VS_BASAL
-0.08596 -0.12341 -0.15195 -0.13997 -0.09014NCI_BETA_OXIDATION_OF_DECANOYL_COA_TO_OCTANOYL_COA_COA
-0.02222 -0.00002 -0.00286 -0.08413 -0.00903GOLDRATH_ANTIGEN_RESPONSE
-0.00508 -0.05827 -0.00602 -0.03996 -0.00183NCI_FOXM1PATHWAY
-0.00718 -0.11862 -0.00124 -0.08620 -0.00148NCI_TRANSFORMATION_OF_LANOSTEROL_TO_CHOLESTEROL
-0.02705 -0.00026 -0.00012 -0.16095 -0.01003BENPORATH_CYCLING_GENES
-0.00115 -0.00001 -0.00013 -0.02468 -0.00039REACTOME_ELECTRON_TRANSPORT_CHAIN
-0.00372 -0.00078 -0.12135 -0.00021 -0.00233YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_12
-0.05578 -0.06084 -0.01579 -0.07556 -0.09387OHASHI_AURKB_TARGETS
-0.06224 -0.00378 -0.00069 -0.05125 -0.04330CORUM_RC_COMPLEX_DURING_G2/M-PHASE_OF_CELL_CYCLE
-0.00018 -0.00001 -0.00617 -0.00628 -0.00033YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_13
-0.00236 -0.00001 -0.06903 -0.01552 -0.00043KEGG_PARKINSONS_DISEASE
-0.02012 -0.00016 -0.01315 -0.00274 -0.02101PRAMOONJAGO_SOX4_TARGETS_DN
-0.00684 -0.00796 -0.03486 -0.08702 -0.00043KEGG_HUNTINGTONS_DISEASE
-0.03792 -0.00518 -0.03769 -0.05383 -0.00853REACTOME_INTEGRATION_OF_ENERGY_METABOLISM
-0.00657 -0.00069 -0.00627 -0.06341 -0.00959LEE_LIVER_CANCER_SURVIVAL_DN
-0.00681 -0.04056 -0.05740 -0.01189 -0.01163KEGG_OOCYTE_MEIOSIS
-0.08934 -0.13468 -0.15609 -0.13483 -0.08527NCI_BETA_OXIDATION_OF_OCTANOYL_COA_TO_HEXANOYL_COA
-0.01433 -0.01053 -0.05067 -0.05605 -0.01507NCI_APC_CDC20_MEDIATED_DEGRADATION_OF_NEK2A
-0.01525 -0.12766 -0.02277 -0.07154 -0.00444KEGG_PROPANOATE_METABOLISM
-0.04914 -0.04260 -0.04967 -0.00913 -0.02860REACTOME_DIABETES_PATHWAYS
-0.00530 -0.00178 -0.00039 -0.05512 -0.00294MOOTHA_MITOCHONDRIA
-0.01593 -0.02945 -0.02032 -0.08492 -0.01232DAIRKEE_TERT_TARGETS_UP
-0.00608 -0.00046 -0.09173 -0.18262 -0.00116TARTE_PLASMA_CELL_VS_B_LYMPHOCYTE_UP
-0.00631 -0.03686 -0.00073 -0.02890 -0.00298STEIN_ESRRA_TARGETS_UP
-0.04603 -0.01642 -0.06171 -0.08659 -0.03512RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_POORLY_UP
-0.00831 -0.00246 -0.03992 -0.00090 -0.00059CHEN_HOXA5_TARGETS_9HR_DN
-0.04108 -0.00119 -0.00167 -0.07322 -0.02279POMEROY_MEDULLOBLASTOMA_PROGNOSIS_DN
-0.03351 -0.00016 -0.00058 -0.08225 -0.07930FINETTI_BREAST_CANCER_BASAL_VS_LUMINAL
-0.01430 -0.02146 -0.09461 -0.07869 -0.01300RAMASWAMY_METASTASIS_UP
-0.01267 -0.10845 -0.12679 -0.13285 -0.00296NCI_RECRUITMENT_OF_MITOTIC_CENTROSOME_PROTEINS_AND_COMPLEXES
-0.02830 -0.00728 -0.01819 -0.03508 -0.00940REACTOME_REGULATION_OF_INSULIN_SECRETION
-0.01848 -0.00004 -0.00242 -0.03223 -0.01642LY_AGING_MIDDLE_DN
-0.04457 -0.10305 -0.06189 -0.08393 -0.01327ACEVEDO_NORMAL_TISSUE_ADJACENT_TO_LIVER_TUMOR_DN
-0.02908 -0.00049 -0.00052 -0.08048 -0.07132FINETTI_BREAST_CANCER_KINOME_RED
-0.00238 -0.01195 -0.04969 -0.10034 -0.00776NCI_INACTIVATION_OF_APC_C_VIA_DIRECT_INHIBITION_OF_THE_APC_C_COMPLEX
-0.18530 -0.02186 -0.12246 -0.08874 -0.05628BIOCARTA_AKAP95_PATHWAY
-0.00740 -0.13553 -0.04825 -0.02846 -0.00278NUYTTEN_NIPP1_TARGETS_DN
-0.00920 -0.03184 -0.05717 -0.09820 -0.01296OUELLET_CULTURED_OVARIAN_CANCER_INVASIVE_VS_LMP_UP
-0.00171 -0.05126 -0.08124 -0.00769 -0.00007NCI_FORMATION_OF_ATP_BY_CHEMIOSMOTIC_COUPLING
-0.11744 -0.00845 -0.06708 -0.18518 -0.12270KEGG_PYRUVATE_METABOLISM
-0.11704 -0.12333 -0.08770 -0.15875 -0.06947CORUM_OLIGOSACCHARYLTRANSFERASE_COMPLEX_STT3B_VARIANT
-0.08118 -0.03038 -0.00101 -0.17471 -0.03156CORUM_RC_COMPLEX_DURING_S-PHASE_OF_CELL_CYCLE
-0.00788 -0.08891 -0.00997 -0.01330 -0.00296CAIRO_HEPATOBLASTOMA_UP
-0.00440 -0.09261 -0.13731 -0.14118 -0.00302KEGG_PROGESTERONE_MEDIATED_OOCYTE_MATURATION
-0.00137 -0.03217 -0.16735 -0.06448 -0.01002REACTOME_PHOSPHORYLATION_OF_THE_APC
-0.03135 -0.00146 -0.02111 -0.13629 -0.01175LINDGREN_BLADDER_CANCER_CLUSTER_1_DN